🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase II single-arm study designed to evaluate the efficacy and s...
Status
Recruiting
Location
Tianjin Medical University Cancer Institute and Hospital
Start Date
2025-04-01
Trial ID
NCT06939127
The primary objective of this study is to assess the safety and tolerabilit...
Status
Completed
Location
Icahn School of Medicine At Mount Sinai
Start Date
2021-03-04
Trial ID
NCT04649385
The purpose of this study was to evaluate the safety and efficacy of ociper...
Status
Terminated
Location
XCancer/Centeral Care Center
Start Date
2021-06-17
Trial ID
NCT04866017
Treatments Being Tested
This study evaluated the efficacy and safety of tislelizumab in combination...
Status
Completed
Location
Anhui Provincial Hospital
Start Date
2018-07-23
Trial ID
NCT03663205
Treatments Being Tested
To explore the related biomarkers for safety and efficacy of the combinatio...
Status
Unknown
Location
Guangzhou Medical University Affiliated Cancer Hospital
Start Date
2020-12-22
Trial ID
NCT05244837
This study aimed to evaluate the safety and effectiveness of ociperlimab co...
Status
Completed
Location
Valkyrie Clinical Trials
Start Date
2021-11-16
Trial ID
NCT05014815
Treatments Being Tested
This is a multicenter, randomized, open-label, phase III clinical study, to...
Status
Recruiting
Location
Beijing Cancer Hospital
Start Date
2025-09-10
Trial ID
NCT07174908
The aim of this clinical trial is to understand whether spatial fractionate...
Status
Recruiting
Location
Nanchang City, Jiangxi Province
Start Date
2025-04-21
Trial ID
NCT07131319
The purpose of the study is to compare the efficacy and safety of SYS6010 i...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-06-25
Trial ID
NCT07672223
This is a randomized, double-blind, phase III clinical study to compare the...
Status
Not Yet Recruiting
Location
The first affiliated hospital of bengbu medical college
Start Date
2023-11-14
Trial ID
NCT05990127
Treatments Being Tested